Can a simple pill delay Parkinson's? new study tests idebenone in sleep disorder patients
NCT ID NCT04534023
First seen Nov 26, 2025 · Last updated May 14, 2026 · Updated 20 times
Summary
This study tests whether the drug idebenone can slow or prevent the progression of a sleep disorder called iRBD into more serious brain diseases like Parkinson's. About 142 adults with iRBD will receive either idebenone or a placebo for up to 5 years. Researchers will track how many people develop Parkinson's or similar conditions using questionnaires, blood tests, and brain scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYNUCLEINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Conditions
Explore the condition pages connected to this study.